Table 4.
Association of CNTN-1 mRNA expression in breast cancer cases with different clinicopathological features.
| Variables | CNTN-1 mRNA expression | p value | |
|---|---|---|---|
| Mean | SD | ||
| Relative expression | 4.92 | 3.02 | — |
|
| |||
| Age | |||
| ≤50 years | 4.35 | 3.88 | 0.03 |
| >50 years | 5.60 | 3.55 | |
|
| |||
| Menopause | |||
| Yes | 4.98 | 3.68 | 0.72 |
| No | 4.81 | 3.99 | |
|
| |||
| Lymph nodes | |||
| Yes | 5.97 | 3.99 | 0.01 |
| No | 4.10 | 3.39 | |
|
| |||
| ER status | |||
| Yes | 5.97 | 4.0 | 0.06 |
| No | 4.45 | 4.59 | |
|
| |||
| PR status | |||
| Yes | 6.19 | 3.90 | 0.03 |
| No | 4.44 | 3.62 | |
|
| |||
| HER2 status | |||
| Yes | 5.92 | 4.21 | 0.04 |
| No | 4.26 | 3.30 | |
|
| |||
| TNM stages | |||
| Early stage (I & II) | 1.72 | 1.24 | <0.0001 |
| Advanced stage (III & IV) | 6.89 | 3.43 | |
|
| |||
| Distant metastases | |||
| Yes | 8.85 | 3.92 | <0.0001 |
| No | 3.68 | 2.74 | |